Previous 10 | Next 10 |
home / stock / pclof / pclof news
2023-08-29 10:19:09 ET PharmaCielo press release ( OTCPK:PCLOF ): Q2 GAAP EPS of -C$0.02. Revenue of C$160,000 vs C$2.12M a year ago. For further details see: PharmaCielo GAAP EPS of -C$0.02
All figures in Canadian dollars ($) unless otherwise specified Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 29, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) (" PharmaCielo " or the " Company "), the Canadian parent of Colombia's premier cultivator and producer of ...
2023-07-11 11:54:41 ET PharmaCielo ( OTCPK:PCLOF ) said on Tuesday that it had appointed Marc Lustig as chairman and chief executive officer. Lustig succeeds Bill Petron, who will continue to remain on the company's board on directors. Lustig has served as the lead direct...
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 11, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia ...
2023-05-29 07:42:10 ET PharmaCielo press release ( OTCPK:PCLOF ): Q1 GAAP EPS of -C$0.02. Revenue of C$0.79M (-34.2% Y/Y). For further details see: PharmaCielo GAAP EPS of -C$0.02, revenue of C$0.79M
The Company has products in various stages of testing and sales with more than 40 customers in 11 countries, with continued growth expected for the year. Q1 2023 revenue of $786,498; Adjusted EBITDA loss of $1.9 million. PharmaCielo continues to focus on operating efficiently, with overhead exp...
Represents PharmaCielo's first shipment to South Africa, which has well-established export networks in the UK and Australia, and other potential markets, globally. Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 16, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCi...
2023-05-01 07:59:17 ET PharmaCielo press release ( OTCPK:PCLOF ): Q4 GAAP EPS of -C$0.02. Revenue of C$1.52M (+347.1% Y/Y). PharmaCielo had cash equivalents of $0.2 million at December 31, 2022, the Company reduced its Adjusted EBITDA loss from $16.4 million For ...
During 2022, PharmaCielo made shipments to 23 clients in 9 countries, with continued growth expected for 2023. The Company's measured investments in revenue-generating sales channels resulted in revenues of $5.3 million in 2022, almost three-times more than the $1.9 million reported in 2021. Co...
Will bring unique high-THC Colombian strains owned by PharmaCielo to Europe for the first time. Combines PharmaCielo's expertise in producing premium medicinal cannabis products, with CANNPRISMA's conversion capabilities, to bring patients in Europe the highest quality high-THC flower product ...
News, Short Squeeze, Breakout and More Instantly...
PharmaCielo Ltd. Company Name:
PCLOF Stock Symbol:
OTCMKTS Market:
PharmaCielo Ltd. (TSXV:PCLO) (OTCQX:PCLOF) revealed its plans to acquire cannabis operations in Thailand. What Happened On Wednesday, the Canadian ...
The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product. Experienced investor, businessman and lawyer Louis Desmarais, the current Chairman and CEO of Siam Ventures, w...
2024-03-27 17:08:02 ET CEO of PharmaCielo, David Attard speaks to shareholders about the short seller report In early March, Hindenburg Research issued a short seller report targeting PharmaCielo's credibility and its stock. Moreover, the Company believes that this report represen...